← Insider buys

Barrett Katz has sold VRDN and made no open-market buys since Jan 2023

Chief Medical Officer at Viridian Therapeutics, Inc.

SEC CIK 0001841628 · Filings on SEC.gov ↗

$0Bought
$3.2MSold
NoneLast buy

Every filing

2 filings since Jan 2023, newest first

Filings come from SEC EDGAR. Not investment advice.